Kristen E. Belmonte

923 total citations
19 papers, 724 citations indexed

About

Kristen E. Belmonte is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Kristen E. Belmonte has authored 19 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Physiology. Recurrent topics in Kristen E. Belmonte's work include Receptor Mechanisms and Signaling (11 papers), Neuropeptides and Animal Physiology (8 papers) and Asthma and respiratory diseases (7 papers). Kristen E. Belmonte is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Neuropeptides and Animal Physiology (8 papers) and Asthma and respiratory diseases (7 papers). Kristen E. Belmonte collaborates with scholars based in United States, United Kingdom and Mali. Kristen E. Belmonte's co-authors include A.D. Fryer, Richard W. Costello, David B. Jacoby, Gerald J. Gleich, Christopher M. Evans, James J. Foley, Marie‐Thérèse Walsh, Md. Matiur Rahaman, Henry M. Sarau and Peter T. Buckley and has published in prestigious journals such as Journal of Neuroscience, The Journal of Physiology and The FASEB Journal.

In The Last Decade

Kristen E. Belmonte

19 papers receiving 701 citations

Peers

Kristen E. Belmonte
H. Meurs Netherlands
Annet B. Zuidhof Netherlands
G. Kurt Hogaboom United States
J. G. Drewett United States
MG Belvisi United Kingdom
Lin Wei Belgium
Pingfang Song United States
H. Meurs Netherlands
Kristen E. Belmonte
Citations per year, relative to Kristen E. Belmonte Kristen E. Belmonte (= 1×) peers H. Meurs

Countries citing papers authored by Kristen E. Belmonte

Since Specialization
Citations

This map shows the geographic impact of Kristen E. Belmonte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristen E. Belmonte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristen E. Belmonte more than expected).

Fields of papers citing papers by Kristen E. Belmonte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristen E. Belmonte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristen E. Belmonte. The network helps show where Kristen E. Belmonte may publish in the future.

Co-authorship network of co-authors of Kristen E. Belmonte

This figure shows the co-authorship network connecting the top 25 collaborators of Kristen E. Belmonte. A scholar is included among the top collaborators of Kristen E. Belmonte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristen E. Belmonte. Kristen E. Belmonte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jin, Qi, Jian Jin, Yonghui Wang, et al.. (2012). Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups. Bioorganic & Medicinal Chemistry Letters. 22(23). 7087–7091. 3 indexed citations
2.
Wan, Zehong, Dramane I. Lainé, Hongxing Yan, et al.. (2009). Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD. Bioorganic & Medicinal Chemistry Letters. 19(16). 4560–4562. 2 indexed citations
3.
Lainé, Dramane I., Zehong Wan, Hongxing Yan, et al.. (2009). Design, Synthesis, and Structure−Activity Relationship of Tropane Muscarinic Acetylcholine Receptor Antagonists. Journal of Medicinal Chemistry. 52(16). 5241–5252. 9 indexed citations
4.
Wang, Yonghui, Feng Wang, Haibo Xie, et al.. (2009). M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines. Bioorganic & Medicinal Chemistry Letters. 19(6). 1686–1690. 4 indexed citations
5.
Lainé, Dramane I., Jérémy Dufour, Katherine L. Widdowson, et al.. (2009). Discovery of Novel 1-Azoniabicyclo[2.2.2]octane Muscarinic Acetylcholine Receptor Antagonists. Journal of Medicinal Chemistry. 52(8). 2493–2505. 16 indexed citations
6.
Jin, Jian, Yonghui Wang, Feng Wang, et al.. (2008). Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas. Bioorganic & Medicinal Chemistry Letters. 18(20). 5481–5486. 2 indexed citations
7.
Jin, Jian, Yonghui Wang, Feng Wang, et al.. (2008). Discovery of Biphenyl Piperazines as Novel and Long Acting Muscarinic Acetylcholine Receptor Antagonists. Journal of Medicinal Chemistry. 51(19). 5915–5918. 13 indexed citations
8.
Lainé, Dramane I., Haibo Xie, James J. Foley, et al.. (2007). Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(22). 6066–6069. 7 indexed citations
9.
Mazzone, Stuart B., Nanako Mori, Miriam Burman, et al.. (2006). Fluorescent styryl dyes FM1‐43 and FM2‐10 are muscarinic receptor antagonists: intravital visualization of receptor occupancy. The Journal of Physiology. 575(1). 23–35. 17 indexed citations
10.
Belmonte, Kristen E.. (2005). Cholinergic Pathways in the Lungs and Anticholinergic Therapy for Chronic Obstructive Pulmonary Disease. Proceedings of the American Thoracic Society. 2(4). 297–304. 169 indexed citations
11.
Rahaman, Md. Matiur, et al.. (2005). Neutrophil Sphingosine 1-Phosphate and Lysophosphatidic Acid Receptors in Pneumonia. American Journal of Respiratory Cell and Molecular Biology. 34(2). 233–241. 53 indexed citations
12.
Waters, Catherine, Jaclyn S. Long, И. А. Горшкова, et al.. (2005). Cell migration activated by platelet‐derived growth factor receptor is blocked by an inverse agonist of the sphingosine 1‐phosphate receptor‐1. The FASEB Journal. 20(3). 509–511. 74 indexed citations
13.
Hardaker, Elizabeth, Amy Roshak, James J. Foley, et al.. (2003). Regulation of TNF‐α and IFN‐γ induced CXCL10 expression: participation of the airway smooth muscle in the pulmonary inflammatory response in chronic obstructive pulmonary disease. The FASEB Journal. 18(1). 191–193. 103 indexed citations
14.
Evans, Christopher M., Kristen E. Belmonte, Richard W. Costello, et al.. (2000). Substance P-induced airway hyperreactivity is mediated by neuronal M2receptor dysfunction. American Journal of Physiology-Lung Cellular and Molecular Physiology. 279(3). L477–L486. 38 indexed citations
16.
Costello, Richard W., Christopher M. Evans, Bethany L. Yost, et al.. (1999). Antigen-induced hyperreactivity to histamine: role of the vagus nerves and eosinophils. American Journal of Physiology-Lung Cellular and Molecular Physiology. 276(5). L709–L714. 66 indexed citations
17.
Costello, Richard W., A.D. Fryer, Kristen E. Belmonte, & David B. Jacoby. (1998). Effects of tachykinin NK1 receptor antagonists on vagal hyperreactivity and neuronal M2 muscarinic receptor function in antigen challenged guinea‐pigs. British Journal of Pharmacology. 124(2). 267–276. 32 indexed citations
18.
Belmonte, Kristen E., A.D. Fryer, & Richard W. Costello. (1998). Role of insulin in antigen-induced airway eosinophilia and neuronal M2muscarinic receptor dysfunction. Journal of Applied Physiology. 85(5). 1708–1718. 56 indexed citations
19.
Belmonte, Kristen E., David B. Jacoby, & A.D. Fryer. (1997). Increased function of inhibitory neuronal M2 muscarinic receptors in diabetic rat lungs. British Journal of Pharmacology. 121(7). 1287–1294. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026